Cerebrospinal fluid tau protein shows a better discrimination in young old (<70 years) than in old old patients with Alzheimer's disease compared with controls
- 29 November 1999
- journal article
- research article
- Published by Elsevier in Neuroscience Letters
- Vol. 277 (1) , 21-24
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Improved discrimination of AD patients using β-amyloid (1-42) and tau levels in CSFNeurology, 1999
- Discriminant power of combined cerebrospinal fluid τ protein and of the soluble interleukin-6 receptor complex in the diagnosis of Alzheimer's disease1Preliminary parts of this study have been presented in abstract form at the 6th International Conference on Alzheimer's Disease and Related Disorders, July 18–23, 1998, Amsterdam, The Netherlands and at the 28th Annual Meeting of the Society for Neuroscience, November 7–12, 1998, Los Angeles, CA, USA.1Brain Research, 1999
- Increased tau in the cerebrospinal fluid of patients with frontotemporal dementia and Alzheimer's diseaseNeuroscience Letters, 1999
- High Cerebrospinal Fluid Tau and Low Amyloid β42 Levels in the Clinical Diagnosis of Alzheimer Disease and Relation to Apolipoprotein E GenotypeArchives of Neurology, 1998
- The psychology of the oldest-oldCurrent Opinion in Psychiatry, 1998
- Consensus Report of the Working Group on: “Molecular and Biochemical Markers of Alzheimer’s Disease”Neurobiology of Aging, 1998
- Memory Performances in Young, Elderly, and Very Old Healthy Individuals versus Patients with Alzheimer's Disease: Evidence for Discontinuity Between Normal and Pathological AgingJournal of Clinical and Experimental Neuropsychology, 1998
- Assessment of CSF levels of tau protein in mildly demented patients with Alzheimer's diseaseNeurology, 1997
- Tau in cerebrospinal fluid: A potential diagnostic marker in Alzheimer's diseaseAnnals of Neurology, 1995
- The prevalence of dementia: A quantitative integration of the literatureActa Psychiatrica Scandinavica, 1987